Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • nseh
    Junior Member
    • May 2011
    • 3

    Problems with Picards MarkDuplicates

    Hi all,

    When running Picards MarkDuplicates I get the following error:

    Exception in thread "main" java.lang.RuntimeException: SAM validation error: ERROR: Record 124760536, Read name B80PDAABXX:1:26
    :2364:123720#0, MAPQ should be 0 for unmapped read.
    at net.sf.samtools.SAMUtils.processValidationErrors(SAMUtils.java:334)
    at net.sf.samtools.BAMFileReader$BAMFileIterator.advance(BAMFileReader.java:469)
    at net.sf.samtools.BAMFileReader$BAMFileIterator.next(BAMFileReader.java:450)
    at net.sf.samtools.BAMFileReader$BAMFileIterator.next(BAMFileReader.java:417)
    at net.sf.samtools.SAMFileReader$AssertableIterator.next(SAMFileReader.java:629)
    at net.sf.samtools.SAMFileReader$AssertableIterator.next(SAMFileReader.java:607)
    at net.sf.picard.sam.MarkDuplicates.buildSortedReadEndLists(MarkDuplicates.java:276)
    at net.sf.picard.sam.MarkDuplicates.doWork(MarkDuplicates.java:113)
    at net.sf.picard.cmdline.CommandLineProgram.instanceMain(CommandLineProgram.java:158)
    at net.sf.picard.sam.MarkDuplicates.main(MarkDuplicates.java:97)

    It says that MAPQ should be 0 for unmapped reads, and this sounds reasonable. But could it be that something went wrong earlier in the analysis? Hope anyone can help!

    Nat.
  • swbarnes2
    Senior Member
    • May 2008
    • 910

    #2
    This is a common problem, and you'll run into it with all the Picard suite of tools.

    There's a setting that goes something like VALIDATION_STRINGENCY, and if you set it to LENIENT, it will complain about those reads, but it won't stop on them.

    This happens with bwa, because it concatenates reference sequence, which leads to slightly odd things happening when a read aligns over the overlap. So this might be the source of your problem. Regardless of what's causing it, you can examine the problem reads, and cut them out, or change the stringency to let them go through.

    Comment

    • nseh
      Junior Member
      • May 2011
      • 3

      #3
      Thank you! It works

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 12:17 PM
      0 responses
      13 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      12 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      37 views
      0 reactions
      Last Post SEQadmin2  
      Working...